Penn State Hershey Cancer Institute, Pennsylvania State College of Medicine, Hershey, 17033, USA.
Anticancer Agents Med Chem. 2011 Nov;11(9):810-7. doi: 10.2174/187152011797655041.
Sphingosine 1-phosphate (S1P) is a bioactive lipid with diverse biological functions, including cell proliferation, differentiation, angiogenesis, chemotaxis, and migration. Many of the activities of S1P are mediated through five closely related G-protein-coupled receptors of the sphingosine-1-phosphate receptor family (S1PR) which play a crucial role in sphingolipid metabolism. Each of these receptors appears to be tissue specific and to have demonstrated roles in the regulation of cell proliferation and survival in various cancer types. Further analysis of the function that S1PRs serve in hematological malignancies offers a great potential for the discovery of novel and selective therapeutic agents targeting these receptors. This review focuses on the characterization of S1PRs and their roles in cancer development in various signaling pathways mediated through specific G coupled protein. In particular, pharmacological agents targeting these S1PRs will be discussed and their potential will be examined.
鞘氨醇 1-磷酸(S1P)是一种具有多种生物学功能的生物活性脂质,包括细胞增殖、分化、血管生成、趋化性和迁移。S1P 的许多活性是通过鞘氨醇-1-磷酸受体家族(S1PR)的五个密切相关的 G 蛋白偶联受体介导的,这些受体在鞘脂代谢中起着至关重要的作用。这些受体中的每一个似乎都具有组织特异性,并在各种癌症类型中证明了在调节细胞增殖和存活方面的作用。进一步分析 S1PR 在血液恶性肿瘤中的功能为发现针对这些受体的新型和选择性治疗药物提供了巨大的潜力。本文综述了 S1PR 的特征及其在各种信号通路中通过特定 G 蛋白偶联蛋白介导的癌症发展中的作用。特别讨论了针对这些 S1PR 的药理学制剂,并对其潜力进行了研究。